Email address
[email protected]Contact number
020 7583 4055Share profile
Band 2
Provided by Nicola Maguire
- Emerging Companies
- Mergers & Acquisitions
- Public Companies
- Life Sciences Corporate Partnering & Licensing
- Intellectual Property
- Healthcare
- Life Sciences
- Medtech
- Venture Capital
Nicola Maguire has developed a practice specialising in advising life sciences companies and other clients whose businesses have a significant reliance on intellectual property.
Many of the transactions on which Nicola works have a significant international element, with parties in the US or Europe. Nicola's experience includes advising on the acquisition for Swedish listed company Meda AB of an Italian specialty pharma company, Rottapharm, for the Danish, listed company Ambu A/S on its acquisition of King Systems, a US subsidiary of UK listed company, Consort Medical, on the creation of an Indian joint venture between the Wellcome Trust and Merck and on the creation of a joint venture between Swedish company, Karolinska Development and UK based Rosetta Capital. Transactions such as this illustrate the cross-border nature of Nicola's practice. She has particular expertise advising clients at all stages of development, from early stage startups to listed companies, and on mergers and acquisitions, joint ventures and equity fundings.
Provided by Chambers
Nicola Maguire handles a range of investments, financing rounds, sales and acquisitions for biotech start-ups and pharmaceutical corporations. She often acts on matters with cross-border and international implications.
Provided by Chambers
Nicola is a responsive and flexible partner.
Nicola is a talented lawyer with a pragmatic approach.
Nicola is a responsive and flexible partner.
Nicola is a talented lawyer with a pragmatic approach.
